Tonix Pharmaceuticals Holding Corp. (TNXP)
16.90
+1.27
(+8.13%)
USD |
NASDAQ |
Jan 14, 16:00
16.99
+0.09
(+0.53%)
After-Hours: 05:37
Tonix Pharmaceuticals EPS Diluted (Quarterly): -3.587 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Amicus Therapeutics, Inc. | 0.0558 |
| Soligenix, Inc. | -0.5846 |
| Citius Oncology, Inc. | -0.0617 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.01M |
| Revenue (Quarterly) | 3.29M |
| Total Expenses (Quarterly) | 35.30M |
| Enterprise Value | -65.29M |
| Gross Profit Margin (Quarterly) | 44.44% |
| Profit Margin (Quarterly) | -972.9% |
| Earnings Yield | -5.84K% |
| Normalized Earnings Yield | -5838.70 |